Ferric Oxide
CAS 1309-37-1
Ferric Oxide (CAS 1309-37-1) is a pharmaceutical compound with 0 bioactivity targets and 14 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| IRON OXIDES | 1310572 | SU | MTHSPL |
| CI 77491 | 1310572 | SU | MTHSPL |
| HEMATITE | 1310572 | SU | MTHSPL |
| FERRIC OXIDE RED | 1310572 | SU | MTHSPL |
| FERRIC OXIDE | 1310572 | SU | MTHSPL |
| Ferric Oxide Red | 1310572 | SU | MTHSPL |
| Ferric oxide red | 1310572 | SU | MTHSPL |
| ferric oxide red | 1310572 | SU | MTHSPL |
| Ferric oxide Red | 1310572 | SU | MTHSPL |
| ferric oxide | 1310572 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ferric Oxide used for in pharmaceutical contexts?
Ferric Oxide (CAS 1309-37-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ferric Oxide?
Ferric Oxide has 14 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Contraindicated product administered, Foetal distress syndrome, Foetal exposure during pregnancy, Foetal growth restriction, Low birth weight baby. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ferric Oxide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Iron Oxides (CI 77491, CI 77492, CI 77499) with EU status "permitted".
What clinical phase is Ferric Oxide in?
No phase 1-4 clinical development badge is rendered for Ferric Oxide because the matched compound identifier rows do not contain a max-phase value.